Phase I Study of Intrathecal Mafosfamide

NCT00001251 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

NIH

Sponsor class

Conditions

Leukemia
Lymphoma
Meningeal Neoplasm

Interventions

DRUG: Mafosfamide

Sponsor

National Cancer Institute (NCI)